MK
Mukeshbhai Kanubhai Pokiya
About Mukeshbhai Kanubhai Pokiya
Data last updated:
Mukeshbhai Kanubhai Pokiya is a Director at Axelus Pharma Private Limited (since 2018). The company operates in Pharma. Axelus Pharma Private Limited reported revenue of ₹3.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Dec 2018 | 2018 | ₹3.45 Cr (FY 2025) | Active |
Board colleagues of Mukeshbhai Kanubhai Pokiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhailalbhai Khodabhai Bhesaniya | 08329895 | Axelus Pharma Private Limited | Director |
| Dhavalkumar Maganbhai Dobariya | 08302413 | Axelus Pharma Private Limited | Director |
| Ghanshyambhai Manubhai Bhesaniya | 08302392 | Axelus Pharma Private Limited | Director |
| Haribhai Popatbhai Kukadiya | 10528324 | Axelus Pharma Private Limited | Director |
| Rajeshbhai Dhirajlal Devani | 08329894 | Axelus Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukeshbhai Kanubhai Pokiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukeshbhai Kanubhai Pokiya
Mukeshbhai Kanubhai Pokiya currently holds 1 directorship: Axelus Pharma Private Limited (Director, since 12 Dec 2018, revenue ₹3.45 Cr (FY 2025)).
Mukeshbhai Kanubhai Pokiya was first appointed on 12 Dec 2018 as Director at Axelus Pharma Private Limited.
The current boards of Mukeshbhai Kanubhai Pokiya's companies include Bhailalbhai Khodabhai Bhesaniya (Axelus Pharma Private Limited), Dhavalkumar Maganbhai Dobariya (Axelus Pharma Private Limited), Ghanshyambhai Manubhai Bhesaniya (Axelus Pharma Private Limited), Haribhai Popatbhai Kukadiya (Axelus Pharma Private Limited), Rajeshbhai Dhirajlal Devani (Axelus Pharma Private Limited).